藥物成份

共有 21678 個藥物成份

Optium Blood Glucose Electrode：\n Glucose dehydrogenase (Microbial) ≧ 0.04U,\n NAD+ (as sodium salt) ≧ 5.4 μg, \n Phenanthroline quinine ≧ 0.3 μg,\n Non-reactive ingredients ≧ 12.0 μg\nOptium Blood β-Ketone Test Strip：\n β-hydroxybutyrate dehydrogenase (Pseudomonas sp.)≧ 0.06 IU, \n Other non-reactive ingredients ≧ 90 μg

• 關聯藥證數量: 1

Organic quaternary ammonium salt 6.8 g/L\nKCN 5.8 g/L\nSodium Nitroprussisde(Na2Fe(CN5)NO) 1.1 g/L

• 關聯藥證數量: 1

Orhto-Phthalaldehyde.....0.60%\nPotassium Phosphate.....0.19%\nCitric Acid.....<1%\nDipotassium Phosphate.....<1%\nN-(hydroxyethyl)-ethylenediaminetriacetic acid (HEDTA).....<1%\nBenzotriazole.....0.01%\nD&C Green Dye NO.5.....<1%\nDeionized Water.....95-100%\n以下空白

• 關聯藥證數量: 1

Orlistat It contains not less than 98.0% and not more than 101.5%, calculated on the anhydrous and solvent-free basis.

• 關聯藥證數量: 1

Orlistat contains 98.0% ~ 101.5% of C29H53NO5, calculated on the anhydrous, solvent-free basis.

• 關聯藥證數量: 1

Orlistat contains NLT 98.0% and NMT 101.5% of C29H35NO5, calculated on the anhydrous, solvent-free basis.

• 關聯藥證數量: 1

Orlistat contains NLT 98.0% and NMT 101.5% of C29H53NO5, calculated on the anhydrous, solvent-free basis.

• 關聯藥證數量: 1

Orlistat contains NLT 98.0% and NMT101.5% of C29H53NO5, calculated on the anhydrous, solvent free basis.

• 關聯藥證數量: 1

Orlistat contains not less than 98.0 percent and not more than 101.5 percent of C29H53NO5, calculated on dried basis.

• 關聯藥證數量: 1

Orlistat contains not less than 98.0% and not more than 101.0% of C29H53NO5, calculated on the dried basis.

• 關聯藥證數量: 1

Orlistat contains not less than 98.0% and not more than 101.5% of C29H53NO5, calculated on the anhydrous, solvent-free basis.

• 關聯藥證數量: 1

Orlistat contains not less than 98.0% and not more than 101.5.0% of C29H53NO5 calculated on the anhydrous substance.

• 關聯藥證數量: 1

Orotic Acid Monohydrate contains not less than 98.0% of C5H4N2O4, calculated on the dried basis.

• 關聯藥證數量: 1

Orphenadrine Citrate contains not less than 98.5 % and not more than 101.0% of C24H31NO8, calculated on dried substance.

• 關聯藥證數量: 1

Orphenadrine Citrate contains not less than 98.5% and not more than 101.0% of C18H23NO.C6H8O7 calculated on the dried basis.

• 關聯藥證數量: 1

Orphenadrine Citrate contains not less than 98.5% and not more than 101.0% of C18H23NO‧C6H8O7, calculated on the dried basis.

• 關聯藥證數量: 1

Orphenadrine Citrate contains not less than 98.5% and not more than the equivalent of 101.0% of C18H23NO. C6H8O7, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Oseltamivir Phosphate Form A contains not less than 98.0% and not more than 102.0% of C16H28N2O8P, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Oseltamivir Phosphate contains NLT 98.0% and NMT 101.5% of C16H28N2O4‧H3PO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Oseltamivir Phosphate contains NLT 98.0% and NMT 102.0% of C16H28N2O4‧H3PO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Oseltamivir Phosphate contains not less than 98.0% and not more than 101.5% of C16H28N2O4．H3PO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Oseltamivir Phosphate contains not less than 98.0% and not more than 102.0% of C16H31N2O8P, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Oseltamivir Phosphate, Not less than 98.0% and Not more than 102.0% W/W.

• 關聯藥證數量: 1

Oseltamivir phosphate contains not less than 98.0% and not more than 101.5% of C16H28N2O4•H3PO4, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Oteracil Potassium contains 98.5%~101.5% (on dried basis)

• 關聯藥證數量: 1

Other Ingredients 0.01% sodium azide; stabilizers

• 關聯藥證數量: 1

Other Ingredients\nReagent 1 (R1)：Organic salt, proteins, inorganic polymer, protease inhibitor, surfactant, preservative.\nReagent 2 (R2)：Buffers, inorganic salt, organic salt, proteins, inorganic polymer, protease inhibitor, biological material, stabilizer, surfactant, preservatives.

• 關聯藥證數量: 1

Other ingredients

• 關聯藥證數量: 1

Otilonium Bromide contains not less than 98.0% and not more than 102.0% of C29H43O4N2Br (on dried substance)

• 關聯藥證數量: 1

Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254 measured as amount of total protein containing the PorA P1.4

• 關聯藥證數量: 1

Oxacillin 1ug/disk

• 關聯藥證數量: 1

Oxacillin Sodium contains the equivalent of not less than 815ug and not more than 950ug of oxacillin (C19H19N3O5S) per mg.

• 關聯藥證數量: 1

Oxalate Reagent A \nOxalate Reagent B\nSample diluent\nSample purifier tubes\nOxalate urine controls Elevated\nOxalate urine controls Normal\nOxalate Standard

• 關聯藥證數量: 1

Oxalate Reagent A: DMAB 3.2mmol/l, MBTH 0.2 mmol/l, Buffer pH3.1± 0.1.\nOxalate Reagent B: Oxalate Oxidase 300 u/l, Peroxidase 100000 u/l.\nSample diluent: EDTA 10 mmol/l, Buffer pH7.6±0.1.\nSample purifier: Activated Charcoal.

• 關聯藥證數量: 1

Oxaliplatin Content：Not less than 98.0 percent and not more than 102.0 percent, calculated on the dried basis.

• 關聯藥證數量: 1

Oxaliplatin contains not less than 98.0% and not more than 102.0% of C8H14N2O4Pt, calculated on the dried substance.

• 關聯藥證數量: 1

Oxazepam contains not less than 98.0% and not more than 102.0% of C15H11ClN2O2, calculated on the dried basis.

• 關聯藥證數量: 1

Oxazepam contains not less than 99.0% and not more than 101.0% of C15H11ClN2O2, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Oxazolam contains not less than 99.0% of C18H17ClN2O2, calculated on the dried basis.

• 關聯藥證數量: 1

Oxcarbazepine contains NLT 98.0% and NMT 102.0% of oxcarbazepine(C15H12N2O2), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Oxcarbazepine contains not less than 98.0% and not more than the equivalent of 102.0% of 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepine-5-carboxamide, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Oxgall 20 g\nTSA 40 g\nEsculin 1 g\nFerric Ammomium Citrate 0.5 g\nS.P.S. 0.25 g\nAgar 0.5 g\nGentamicin 0.1 g\nHemin (1%) 1 ml\npure water 1,000 ml \n \n

• 關聯藥證數量: 1

Oxitriptan contains NLT 99.0% and NMT 101.0% of HClO4 titration on the dry basis.

• 關聯藥證數量: 1

Oxolamine Citrate 99.0%-101.0%(dried substance)

• 關聯藥證數量: 1

Oxolamine Citrate contains not less than 98.0% and not more than 102.0% of C14H19N3O.C6H8O7, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Oxolamine Citrate contains not less than 99.0 % and not more than 101.0 % of C14H19N3O‧C6H8O7, calculated on the dried basis.

• 關聯藥證數量: 1

Oxolamine Citrate contains not less than 99.0% and not more than 101.0% of C14H19N3O．C6H8O7, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Oxolamine Citrate contains not less than 99.0% and not more than 101.0% of C20H27N3O8 calculated on dried substance.

• 關聯藥證數量: 1

Oxolamine citrate contains not less than 99.0% and not more than 101.0% of C14H19N3O.C6H8O7, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Oxolamine citrate contains not less than 99.0% and not more than 101.0% of C14H19N3O‧ C6H8O7,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Oxybutynin Chloride contains not less than 97.0% and not more than 101.0% of C22H31NO3？HCl,calculated on the dried basis.

• 關聯藥證數量: 1

Oxybutynin Chloride contains not less than 97.0% and not more than 102.0% of C22H31NO3。HCl, calculated on the dried basis.

• 關聯藥證數量: 1

Oxybutynin Hydrochloride contains not less than 99.0% and not more than 102.0% of C22H31NO3‧HCl, calculated on the dried basis.

• 關聯藥證數量: 1

Oxybutynin contains not less than 97.0% and not more than 101.0% of C22H31NO3, calculated on dried basis.

• 關聯藥證數量: 1

Oxycodone HCL contains not less than 98.5 percent and not more than 101.5 percent of C18H21NO4‧HCL, calculated on the dried basis.

• 關聯藥證數量: 1

Oxycodone Hcl Assay 98.5 % to 101.5 % (anhydrous substance).

• 關聯藥證數量: 1

Oxygen (O2) Contains not less than 99.0% (v/v).

• 關聯藥證數量: 1

Oxygen (O2) contain not less than 99.0% (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains less than 99.0%(v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains more than 99.0% (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains more than 99.50% (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains no less than 99.5 % (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.0 % (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.0% (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.0% (v/v).

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.0% (v/v)。

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.0%(v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.5 % (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.5% (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.5% (v/v).

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.5% \n(v/v).

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.5%(v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.6% (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than 99.6%(v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not less than less than 99.0% (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contains not lessthan 99.5% (v/v)

• 關聯藥證數量: 1

Oxygen (O2) contians not less than 99.0%(v/v).

• 關聯藥證數量: 1

Oxygen (O2)contains not less than 99.0%(v/v)

• 關聯藥證數量: 1

Oxygen contains not less than 99.0% (v/v)

• 關聯藥證數量: 1

Oxygen contains not less than 99.0%(v/v)

• 關聯藥證數量: 1

Oxygen(O2) contains not less than 99.0% (v/v)

• 關聯藥證數量: 1

Oxygen(O2) contains not less than 99.0%(v/v)

• 關聯藥證數量: 1

Oxygen(O2) contains not less than 99.5% (v/v)

• 關聯藥證數量: 1

Oxymetazoline HCl contains not less than 98.5% and not more than 101.5% of C16H24N2O. HCl calculated on the dried basis.

• 關聯藥證數量: 1

Oxymetazoline Hydrochloride contains not less than 99.0 percent and not more than 101.0 percent of C16H24N2O‧HCl, calculated on the dried basis.

• 關聯藥證數量: 1

Oxytetracycline Hydrochloride contains 95.0 percent to 102.0 percent (anhydrous substance)

• 關聯藥證數量: 1

Oxytetracycline hydrochloride contains NLT 95.0% and NMT 102.0% of C22H25ClN2O9, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Oxytocin contains not less than 93.0% and not more than the equivalent of 102.0% of the peptide C43H66N12O12S2,calculated with reference to the anhydrous,acetic acid-free substance.

• 關聯藥證數量: 1

O號透明膠囊

• 關聯藥證數量: 1

P Pretreatment Solution. Aqueous salt solution(3.5ml)

• 關聯藥證數量: 1

P-1 Medium supplemented with 10% Serum Substitute Supplement (SSS), total protein concentration of 6 mg/mL. gentamicin sulfate.

• 關聯藥證數量: 1

P-ALPHA-DIMETHYLBENZYL ALCOHOL

• 關聯藥證數量: 1

P-G Tong Extract (芍藥甘草湯濃縮散)

• 關聯藥證數量: 1

P-METHOXY-ACETOPHENONE

• 關聯藥證數量: 1

P-STEAROYLAMINOPHENYL TRIMETHYLAMMONIUM METHYLSULF

• 關聯藥證數量: 1

P.E.G.400

• 關聯藥證數量: 1

P1 REASSORTANT

• 關聯藥證數量: 1

P1: 50μL reconstituted 1 vial of lyophilize ActivatorF.\nP2-ADP: 100μL reconstituted 1 vial of lyophilize ADP; final concentration 2 μL.\nP3-AA: 100μL reconstituted 1 vial of lyophilize AA; final concentration 1 mM.\nREF6300: 1 vial kaolin \n

• 關聯藥證數量: 1

PAB ANTIBODY.............5MLSODIUM AZIDE<0.1(W/W)

• 關聯藥證數量: 1

PALM KERNEL OIL

• 關聯藥證數量: 1